Title:
INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS AND USE OF SAME IN MEDICINE
Document Type and Number:
WIPO Patent Application WO/2019/129114
Kind Code:
A1
Abstract:
The present invention relates to compounds as shown in formula I, pharmaceutical compositions comprising the compound of formula I, a method for inhibiting an indoleamine 2,3-dioxygenase using same and the use of same in medicine. (I)
More Like This:
Inventors:
LI PAN (CN)
WEN QIAODONG (CN)
WANG JI (CN)
GAN QUAN (CN)
LU YANG (CN)
YANG DONGHUI (CN)
WEN QIAODONG (CN)
WANG JI (CN)
GAN QUAN (CN)
LU YANG (CN)
YANG DONGHUI (CN)
Application Number:
PCT/CN2018/124110
Publication Date:
July 04, 2019
Filing Date:
December 27, 2018
Export Citation:
Assignee:
ADLAI NORTYE BIOPHARMA CO LTD (CN)
International Classes:
C07D215/12; A61K31/47; C07D215/02; C07D215/04
Domestic Patent References:
WO2013134518A1 | 2013-09-12 | |||
WO2017192813A1 | 2017-11-09 |
Foreign References:
CN107663159A | 2018-02-06 | |||
CN101479249A | 2009-07-08 | |||
CN1678586A | 2005-10-05 | |||
CN107427499A | 2017-12-01 |
Attorney, Agent or Firm:
UNITALEN ATTORNEYS AT LAW (CN)
Download PDF:
Previous Patent: AIR INTAKE PIPE USED FOR COMPRESSOR SYSTEM AND COMPRESSOR SYSTEM
Next Patent: SYSTEM HANDOVER METHOD AND COMMUNICATION ENTITY
Next Patent: SYSTEM HANDOVER METHOD AND COMMUNICATION ENTITY